Multicenter phase I clinical trial of daily and weekly RAD001 in combination with vinorelbine and trastuzumab in patients with HER2-overexpressing metastatic breast cancer with prior resistance to trastuzumab
2008 ◽
Vol 26
(15_suppl)
◽
pp. 1057-1057
◽
Keyword(s):
Phase I
◽
2019 ◽
Vol 25
(17)
◽
pp. 5212-5220
◽